Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 7 of 16 found articles
 
 
  Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer
 
 
Title: Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer
Author: von Pawel, Joachim
Harvey, Jimmie H.
Spigel, David R.
Dediu, Mircea
Reck, Martin
Cebotaru, Cristina L.
Humphreys, Robin C.
Gribbin, Matthew J.
Fox, Norma Lynn
Camidge, D. Ross
Appeared in: Clinical lung cancer
Paging: Volume 15 (2014) nr. 3 pages 19413 p.
Year: 2014
Contents:
Publisher: Elsevier Inc.
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 7 of 16 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands